Ablation of cardiac myosin–binding protein-C accelerates contractile kinetics in engineered cardiac tissue

Hypertrophic cardiomyopathy (HCM) caused by mutations in cardiac myosin–binding protein-C (cMyBP-C) is a heterogenous disease in which the phenotypic presentation is influenced by genetic, environmental, and developmental factors. Though mouse models have been used extensively to study the contractile effects of cMyBP-C ablation, early postnatal hypertrophic and dilatory remodeling may overshadow primary contractile defects. The use of a murine engineered cardiac tissue (mECT) model of cMyBP-C ablation in the present study permits delineation of the primary contractile kinetic abnormalities in an intact tissue model under mechanical loading conditions in the absence of confounding remodeling events. We generated mechanically integrated mECT using isolated postnatal day 1 mouse cardiac cells from both wild-type (WT) and cMyBP-C–null hearts. After culturing for 1 wk to establish coordinated spontaneous contraction, we measured twitch force and Ca2+ transients at 37°C during pacing at 6 and 9 Hz, with and without dobutamine. Compared with WT, the cMyBP-C–null mECT demonstrated faster late contraction kinetics and significantly faster early relaxation kinetics with no difference in Ca2+ transient kinetics. Strikingly, the ability of cMyBP-C–null mECT to increase contractile kinetics in response to adrenergic stimulation and increased pacing frequency were severely impaired. We conclude that cMyBP-C ablation results in constitutively accelerated contractile kinetics with preserved peak force with minimal contractile kinetic reserve. These functional abnormalities precede the development of the hypertrophic phenotype and do not result from alterations in Ca2+ transient kinetics, suggesting that alterations in contractile velocity may serve as the primary functional trigger for the development of hypertrophy in this model of HCM. Our findings strongly support a mechanism in which cMyBP-C functions as a physiological brake on contraction by positioning myosin heads away from the thin filament, a constraint which is removed upon adrenergic stimulation or cMyBP-C ablation.

[1]  R. Robinson,et al.  β2-Adrenergic Receptor Actions in Neonatal and Adult Rat Ventricular Myocytes , 1995 .

[2]  M. Gautel,et al.  cAPK‐phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin‐S2 in an on‐off fashion , 1999, FEBS letters.

[3]  R. Moss,et al.  Ablation of myosin-binding protein-C accelerates force development in mouse myocardium. , 2006, Biophysical journal.

[4]  S. Sadayappan,et al.  Phosphorylation and function of cardiac myosin binding protein-C in health and disease. , 2010, Journal of molecular and cellular cardiology.

[5]  D. Bers,et al.  Relaxation of rabbit ventricular muscle by Na-Ca exchange and sarcoplasmic reticulum calcium pump. Ryanodine and voltage sensitivity. , 1989, Circulation research.

[6]  J. Potter,et al.  The effect of troponin I phosphorylation on the Ca2+-binding properties of the Ca2+-regulatory site of bovine cardiac troponin. , 1982, The Journal of biological chemistry.

[7]  H. Granzier,et al.  Protein Kinase A Phosphorylates Titin’s Cardiac-Specific N2B Domain and Reduces Passive Tension in Rat Cardiac Myocytes , 2002, Circulation research.

[8]  J. Ross,et al.  Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice. , 2004, Cardiovascular research.

[9]  R. Moss,et al.  Neonatal Mouse–Derived Engineered Cardiac Tissue: A Novel Model System for Studying Genetic Heart Disease , 2011, Circulation research.

[10]  E. Kranias,et al.  Phosphorylation and functional modifications of sarcoplasmic reticulum and myofibrils in isolated rabbit hearts stimulated with isoprenaline. , 1985, The Biochemical journal.

[11]  L. Carrier,et al.  Cardiac Myosin-Binding Protein C Is Required for Complete Relaxation in Intact Myocytes , 2007, Circulation research.

[12]  R. Moss,et al.  Differential Roles of Cardiac Myosin-Binding Protein C and Cardiac Troponin I in the Myofibrillar Force Responses to Protein Kinase A Phosphorylation , 2007, Circulation research.

[13]  S. Winegrad.  Regulation of Cardiac Contractile Proteins , 1984 .

[14]  K. McDonald,et al.  Loaded Shortening, Power Output, and Rate of Force Redevelopment Are Increased With Knockout of Cardiac Myosin Binding Protein-C , 2003, Circulation research.

[15]  S. Shroff,et al.  Engineered early embryonic cardiac tissue retains proliferative and contractile properties of developing embryonic myocardium. , 2006, American journal of physiology. Heart and circulatory physiology.

[16]  James O. Mudd,et al.  Control of In Vivo Contraction/Relaxation Kinetics by Myosin Binding Protein C: Protein Kinase A Phosphorylation–Dependent and –Independent Regulation , 2007, Circulation.

[17]  D. Kass,et al.  Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. , 1999, The Journal of clinical investigation.

[18]  F. T. ten Cate,et al.  Cardiac Myosin-Binding Protein C Mutations and Hypertrophic Cardiomyopathy: Haploinsufficiency, Deranged Phosphorylation, and Cardiomyocyte Dysfunction , 2009, Circulation.

[19]  M. Regnier,et al.  Effects of the N-terminal Domains of Myosin Binding Protein-C in an in Vitro Motility Assay , 2006, Journal of Biological Chemistry.

[20]  C. Ruwhof,et al.  Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. , 2000, Cardiovascular research.

[21]  S. Harris,et al.  In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament. , 2011, Circulation research.

[22]  R. Moss,et al.  C‐protein limits shortening velocity of rabbit skeletal muscle fibres at low levels of Ca2+ activation. , 1991, The Journal of physiology.

[23]  Wolfgang A. Linke,et al.  Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension , 2006, Journal of Muscle Research & Cell Motility.

[24]  P. Janssen.  Kinetics of cardiac muscle contraction and relaxation are linked and determined by properties of the cardiac sarcomere. , 2010, American journal of physiology. Heart and circulatory physiology.

[25]  J. Shaffer,et al.  Binding of the N-terminal fragment C0-C2 of cardiac MyBP-C to cardiac F-actin. , 2011, Journal of structural biology.

[26]  S. Winegrad,et al.  Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  W. Dong,et al.  Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C. , 1997, Biochemistry.

[28]  P. Powers,et al.  Acceleration of Crossbridge Kinetics by Protein Kinase A Phosphorylation of Cardiac Myosin Binding Protein C Modulates Cardiac Function , 2008, Circulation research.

[29]  H. Watkins,et al.  Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion. , 2003, Trends in genetics : TIG.

[30]  Jonathan Seidman,et al.  Genetic causes of human heart failure. , 2005, The Journal of clinical investigation.

[31]  R. Schwinger,et al.  S arcoplasmic reticulum Ca -ATPase modulates cardiac contraction and relaxation , 2002 .

[32]  J. Shaffer,et al.  The Myosin-binding Protein C Motif Binds to F-actin in a Phosphorylation-sensitive Manner* , 2009, Journal of Biological Chemistry.

[33]  M. Gautel,et al.  Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. , 1999, Journal of molecular biology.

[34]  G. Taffet,et al.  Exercise training improves lusitropy by isoproterenol in papillary muscles from aged rats. , 1996, Journal of applied physiology.

[35]  S. Maulik,et al.  Oxidative stress and cardiac hypertrophy: a review , 2012, Toxicology mechanisms and methods.

[36]  Yiming Wu,et al.  Cardiac Hypertrophy and Reduced Contractility in Hearts Deficient in the Titin Kinase Region , 2007, Circulation.

[37]  A. Coulton,et al.  Cardiac myosin binding protein C and its phosphorylation regulate multiple steps in the cross-bridge cycle of muscle contraction. , 2012, Biochemistry.

[38]  G. Guerrero-Serna,et al.  Designing heart performance by gene transfer. , 2008, Physiological reviews.

[39]  D. Bers,et al.  A Critical Function for Ser-282 in Cardiac Myosin Binding Protein-C Phosphorylation and Cardiac Function , 2011, Circulation research.

[40]  R. Moss,et al.  Ablation of Cardiac Myosin-Binding Protein-C Accelerates Stretch Activation in Murine Skinned Myocardium , 2006, Circulation research.

[41]  D. Zawieja,et al.  Roles of phosphorylation of myosin binding protein‐C and troponin I in mouse cardiac muscle twitch dynamics , 2004, The Journal of physiology.

[42]  P. Powers,et al.  Dissociation of Structural and Functional Phenotypes in Cardiac Myosin-Binding Protein C Conditional Knockout Mice , 2012, Circulation.

[43]  R. Moss,et al.  Protein Kinase A–Mediated Acceleration of the Stretch Activation Response in Murine Skinned Myocardium Is Eliminated by Ablation of cMyBP-C , 2006, Circulation research.

[44]  R. Moss,et al.  Differential roles of regulatory light chain and myosin binding protein‐C phosphorylations in the modulation of cardiac force development , 2010, The Journal of physiology.

[45]  Radial displacement of myosin cross-bridges in mouse myocardium due to ablation of myosin binding protein-C. , 2007, Journal of molecular biology.

[46]  R. Moss,et al.  Protein Kinase A-Mediated Phosphorylation of cMyBP-C Increases Proximity of Myosin Heads to Actin in Resting Myocardium , 2008, Circulation research.

[47]  R. Moss,et al.  In vivo left ventricular functional capacity is compromised in cMyBP-C null mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[48]  Thomas Eschenhagen,et al.  The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy. , 2010, Cardiovascular Research.

[49]  C. Villalba-Galea,et al.  Developmental changes of intracellular Ca2+ transients in beating rat hearts. , 2004, American journal of physiology. Heart and circulatory physiology.

[50]  K. McDonald,et al.  Hypertrophic Cardiomyopathy in Cardiac Myosin Binding Protein-C Knockout Mice , 2002, Circulation research.

[51]  R. Moss,et al.  Myosin binding protein-C phosphorylation is the principal mediator of protein kinase A effects on thick filament structure in myocardium. , 2012, Journal of molecular and cellular cardiology.

[52]  S. Winegrad.  Regulation of cardiac contractile proteins. Correlations between physiology and biochemistry. , 1984, Circulation research.